Publikationen in Zusammenarbeit mit Forschern von Ospedale San Martino (28)

2024

  1. Endourological panorama and current state of training in endourology among European teaching hospitals

    Minerva Urology and Nephrology

  2. HRD testing for all advanced high-grade ovarian carcinoma in first line?

    ESMO Open

  3. Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

    Nature Communications, Vol. 15, Núm. 1

  4. The obesity syndemic in the European community: towards a systems thinking approach for preventive policies

    European heart journal, Vol. 45, Núm. 25, pp. 2181-2182

2023

  1. Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

    Journal of Clinical Oncology, Vol. 41, Núm. 2, pp. 212-221

  2. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis

    Blood, Vol. 141, Núm. 21, pp. 2615-2628

  3. The definition of ideal training of a urology resident from two different perspectives: trainees vs professors. Is there agreement in their idea of good training?

    Central European Journal of Urology, Vol. 76, Núm. 2, pp. 162-166

2022

  1. Evidence-based Medicine: Perceptions, Attitudes, and Skills Among European Urology Residents

    European Urology Open Science, Vol. 45, pp. 44-49

  2. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

    Leukemia, Vol. 36, Núm. 5, pp. 1371-1376

  3. Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity

    Cells, Vol. 11, Núm. 19

  4. ‘Obesities’: Position statement on a complex disease entity with multifaceted drivers

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

2021

  1. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

    American Journal of Hematology, Vol. 96, Núm. 1, pp. 69-79

2020

  1. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

  2. International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

    Liver International, Vol. 40, Núm. 6, pp. 1467-1476

  3. Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial

    Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197

2019

  1. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease

    Biochemical Pharmacology, Vol. 160, pp. 34-45

2018

  1. Obesity phenotypes and their paradoxical association with cardiovascular diseases

    European Journal of Internal Medicine, Vol. 48, pp. 6-17

  2. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227